GEODE CAPITAL MANAGEMENT, LLC - TRACON PHARMACEUTICALS INC ownership

TRACON PHARMACEUTICALS INC's ticker is TCON and the CUSIP is 89237H100. A total of 25 filers reported holding TRACON PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of TRACON PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2019$43,000
-34.8%
97,6730.0%0.00%
Q2 2019$66,000
-15.4%
97,673
+71.4%
0.00%
Q1 2019$78,000
+11.4%
56,974
-50.0%
0.00%
Q4 2018$70,000
-39.7%
113,948
+100.0%
0.00%
Q3 2018$116,000
-24.2%
56,9740.0%0.00%
Q2 2018$153,000
+146.8%
56,974
+110.6%
0.00%
Q1 2018$62,000
-31.1%
27,0570.0%0.00%
Q4 2017$90,000
+5.9%
27,0570.0%0.00%
Q3 2017$85,000
+32.8%
27,0570.0%0.00%
Q2 2017$64,000
-40.2%
27,057
-5.8%
0.00%
Q1 2017$107,000
-23.0%
28,710
+0.8%
0.00%
Q4 2016$139,000
-15.8%
28,488
+16.5%
0.00%
Q3 2016$165,000
+55.7%
24,457
+0.2%
0.00%
Q2 2016$106,000
-37.6%
24,4200.0%0.00%
Q1 2016$170,000
-24.4%
24,420
-0.2%
0.00%
Q4 2015$225,000
+17.8%
24,457
+24.6%
0.00%
Q3 2015$191,000
-8.2%
19,626
+6.6%
0.00%
Q2 2015$208,00018,4170.00%
Other shareholders
TRACON PHARMACEUTICALS INC shareholders Q1 2019
NameSharesValueWeighting ↓
NEA Management Company, LLC 1,889,652$18,462,0001.22%
WALL STREET ASSOCIATES 250,000$2,442,0000.47%
Eventide Asset Management 403,912$3,946,0000.23%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 485,000$4,738,0000.18%
J. Goldman & Co LP 170,000$1,661,0000.14%
QVT Financial LP 363,292$3,549,0000.12%
Kinsight, LLC 10,053$98,0000.07%
Welch Group, LLC 33,769$330,0000.06%
Visium Asset Management, LP 436,336$4,263,0000.06%
Candriam S.C.A. 135,300$1,322,0000.03%
View complete list of TRACON PHARMACEUTICALS INC shareholders